回複:Generics = no big money there - I meant
所有跟帖:
•
yes, it depends....
-MICKEY222-
♀
(0 bytes)
()
03/26/2013 postreply
22:10:00
•
biosimilar, antigenic?
-goodman1978-
♂
(0 bytes)
()
03/26/2013 postreply
22:11:21
•
that is because EMEA had more clear guidence than FDA...
-MICKEY222-
♀
(0 bytes)
()
03/26/2013 postreply
22:16:03
•
哈哈,我算是比較清楚的。。。
-MICKEY222-
♀
(0 bytes)
()
03/26/2013 postreply
22:19:59
•
Brand-name = monopoly . ..
-Fatcat999-
♂
(125 bytes)
()
03/26/2013 postreply
22:17:07
•
if you do not know much about generics, don't talk about it like
-MICKEY222-
♀
(0 bytes)
()
03/26/2013 postreply
22:17:55
•
其實就算是純的generic, 也不是都沒有技術屏障的。就有藥所有專利都過期也沒有人做generic的
-MICKEY222-
♀
(17 bytes)
()
03/26/2013 postreply
22:26:52
•
你一做出來,人家也可以仿? 怎麽仿? 你以為我會把菜譜給他?他要是自己能發現
-MICKEY222-
♀
(31 bytes)
()
03/26/2013 postreply
22:54:41
•
我可以做同樣的??sometime, you can not copy, need to know more about
-MICKEY222-
♀
(174 bytes)
()
03/26/2013 postreply
23:03:29
•
你對這個industry 了解太少了。。
-MICKEY222-
♀
(0 bytes)
()
03/26/2013 postreply
23:09:44
•
Low barrier of entry = low profit of margin . . .
-Fatcat999-
♂
(82 bytes)
()
03/26/2013 postreply
22:27:54
•
建議你多讀些這方麵的文章再來下結論,對投資者來講,ROI重要得多
-MICKEY222-
♀
(0 bytes)
()
03/26/2013 postreply
22:53:18
•
I have worked in this field 20+ years in various capacities . .
-Fatcat999-
♂
(280 bytes)
()
03/27/2013 postreply
05:21:54
•
haha, what you said is exactly just why you do not know. You don
-MICKEY222-
♀
(113 bytes)
()
03/27/2013 postreply
07:11:24
•
Haha, look at the deal between Sirtris and GSK . . .
-Fatcat999-
♂
(297 bytes)
()
03/27/2013 postreply
07:27:30
•
In a free market, high risk = high reward, low risk = low reward
-Fatcat999-
♂
(145 bytes)
()
03/27/2013 postreply
05:41:53
•
high reward does not mean low ROI necessarily...from which stand
-MICKEY222-
♀
(99 bytes)
()
03/27/2013 postreply
07:13:57